Carfilzomib, Cyclophosphamide and dexamethasone (CCD) for newly diagnosed multiple myeloma (MM) patients: initial results of a multicenter, open label phase II study

Ringhen, S.; Cavallo, F.; Mt, Petrucci; Gay, F.; Federico, V.; Conticello, C.; Pantani, L.; Montefusco, V.; Benevolo, G.; Aschero, S.; Offidani, M.; Villani, O.; Siniscalchi, A.; Rossi, D.; Magarotto, V.; Sonneveld, P.; Boccadoro, M.; Palumbo, A.

Links

[www.researchgate.net] | PDF

Tools

Export citation

Search in Google Scholar

Carfilzomib, Cyclophosphamide and dexamethasone (CCD) for newly diagnosed multiple myeloma (MM) patients: initial results of a multicenter, open label phase II study

Proceedings article published in 2013 by S. Ringhen, F. Cavallo, Petrucci Mt, F. Gay, V. Federico, C. Conticello, L. Pantani, V. Montefusco, G. Benevolo, S. Aschero, M. Offidani, O. Villani, A. Siniscalchi, D. Rossi, V. Magarotto and other authors.

This paper is available in a repository.

Full text: Download

Preprint: policy unknown

Upload

Postprint: policy unknown

Upload

Published version: policy unknown

Upload